
Christopher Upton
Examiner (ID: 5454, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1724, 1778, 1306, 1797, 1776, 1308 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17533613
[patent_doc_number] => 20220112222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 17/532109
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532109 | Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography | Nov 21, 2021 | Issued |
Array
(
[id] => 17473948
[patent_doc_number] => 20220081452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 17/532083
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532083
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532083 | Method of preparing zirconium-89 oxine complex | Nov 21, 2021 | Issued |
Array
(
[id] => 17426939
[patent_doc_number] => 20220054647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/518794
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17518794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/518794 | SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF | Nov 3, 2021 | Abandoned |
Array
(
[id] => 17412821
[patent_doc_number] => 20220047725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/451536
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 359
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17451536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/451536 | Chemiluminescent probes for diagnostics and in vivo imaging | Oct 19, 2021 | Issued |
Array
(
[id] => 17369844
[patent_doc_number] => 20220024896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => TAU PET IMAGING LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/450212
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17450212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/450212 | Tau PET imaging ligands | Oct 6, 2021 | Issued |
Array
(
[id] => 17519401
[patent_doc_number] => 20220105249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => X-RAY AND MRI VISIBLE SHAPE MEMORY POLYMER BIOPSY SEALING DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/495009
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17495009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/495009 | X-RAY AND MRI VISIBLE SHAPE MEMORY POLYMER BIOPSY SEALING DEVICE | Oct 5, 2021 | Pending |
Array
(
[id] => 17755578
[patent_doc_number] => 11395857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy
[patent_app_type] => utility
[patent_app_number] => 17/494367
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 18302
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494367 | Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy | Oct 4, 2021 | Issued |
Array
(
[id] => 18340435
[patent_doc_number] => 20230132384
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-04-27
[patent_title] => COMPOSITIONS AND METHODS FOR ASSESSING EYE VASCULATURE
[patent_app_type] => utility
[patent_app_number] => 17/492260
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492260
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492260 | Compositions and methods for assessing eye vasculature | Sep 30, 2021 | Issued |
Array
(
[id] => 18340435
[patent_doc_number] => 20230132384
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2023-04-27
[patent_title] => COMPOSITIONS AND METHODS FOR ASSESSING EYE VASCULATURE
[patent_app_type] => utility
[patent_app_number] => 17/492260
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492260
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492260 | Compositions and methods for assessing eye vasculature | Sep 30, 2021 | Issued |
Array
(
[id] => 19563570
[patent_doc_number] => 12138321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Half-curcuminoids as amyloid-b PET imaging agents
[patent_app_type] => utility
[patent_app_number] => 17/448463
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 17409
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 322
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17448463
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/448463 | Half-curcuminoids as amyloid-b PET imaging agents | Sep 21, 2021 | Issued |
Array
(
[id] => 19472632
[patent_doc_number] => 12102695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Half-curcuminoids as amyloid-beta pet imaging agents
[patent_app_type] => utility
[patent_app_number] => 17/480924
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 17409
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 359
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480924 | Half-curcuminoids as amyloid-beta pet imaging agents | Sep 20, 2021 | Issued |
Array
(
[id] => 18784872
[patent_doc_number] => 20230372554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => SIZE CONTROLLED RADIOLABELLED PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/044678
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044678
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044678 | SIZE CONTROLLED RADIOLABELLED PARTICLES | Sep 14, 2021 | Pending |
Array
(
[id] => 18707697
[patent_doc_number] => 20230330280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => PREPARATIONS OF RADIUM-224 AND PROGENIES FOR USE IN RADIONUCLIDE THERAPY IN COMBINATION WITH DNA REPAIR INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/044665
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044665
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044665 | PREPARATIONS OF RADIUM-224 AND PROGENIES FOR USE IN RADIONUCLIDE THERAPY IN COMBINATION WITH DNA REPAIR INHIBITORS | Sep 14, 2021 | Pending |
Array
(
[id] => 17519065
[patent_doc_number] => 20220104913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => MULTI-MODE IMAGING MARKERS
[patent_app_type] => utility
[patent_app_number] => 17/473820
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17473820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/473820 | Multi-mode imaging markers | Sep 12, 2021 | Issued |
Array
(
[id] => 17443510
[patent_doc_number] => 20220064015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64
[patent_app_type] => utility
[patent_app_number] => 17/466443
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466443
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466443 | Purification process for the preparation of non-carrier added copper-64 | Sep 2, 2021 | Issued |
Array
(
[id] => 17451915
[patent_doc_number] => 11266752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Methods of imaging and delivering therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 17/403429
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 28
[patent_no_of_words] => 19893
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17403429
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/403429 | Methods of imaging and delivering therapeutic agents | Aug 15, 2021 | Issued |
Array
(
[id] => 19195316
[patent_doc_number] => 11992534
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Methods for treating and diagnosing blinding eye diseases
[patent_app_type] => utility
[patent_app_number] => 17/392453
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 40
[patent_no_of_words] => 30797
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392453 | Methods for treating and diagnosing blinding eye diseases | Aug 2, 2021 | Issued |
Array
(
[id] => 17702956
[patent_doc_number] => 20220202962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES
[patent_app_type] => utility
[patent_app_number] => 17/389674
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/389674 | Nitroxide containing amyloid binding agents for imaging and therapeutic uses | Jul 29, 2021 | Issued |
Array
(
[id] => 17227224
[patent_doc_number] => 20210353780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => ASCORBATE FORMULATIONS AND METHODS OF USE AS CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/443863
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443863
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/443863 | Ascorbate formulations and methods of use as contrast agents | Jul 27, 2021 | Issued |
Array
(
[id] => 17297974
[patent_doc_number] => 20210393813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => MULTINUCLEAR COMPLEXES AND THEIR PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/379011
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/379011 | Multinuclear complexes and their preparation | Jul 18, 2021 | Issued |